Lifeboat Foundation

Profusa (South San Francisco, CA) has won a $7.5 million grant from the Defense Advanced Research Projects Agency (DARPA) and the U.S. Army Research Office for further development of its tissue integrated biosensor technology, the company said Tuesday.

The U.S. military sees value in the technology improving mission efficiency through real-time monitoring of combat soldier health status.

Continue reading “DARPA Invests $7.5 Million for Implantable Biosensor that are 3 millimeters long and 500 microns in diameter” »

Woo and other entrepreneurs are using fasts and other tricks to “hack” their brain chemistry like they would a computer, hoping to give themselves an edge as they strive to dream up the next billion-dollar idea. Known by insiders as “biohacking,” the push for cognitive self-improvement is gaining momentum in the Silicon Valley tech world, where workers face constant pressure to innovate and produce at the highest levels.

Great work by my friends at ORNL.

In a review paper published in ACS Nano, Olga Ovchinnikova and colleagues provide an overview of existing paths to 3D materials, but the ultimate goal is to create and customize material at the atomic scale. Material would be assembled atom by atom, much like children can use Legos to build a car or castle brick by brick. This concept, known as directed matter, could lead to virtually perfect materials and products because many limitations of conventional manufacturing techniques would be eliminated.

“Being able to assemble matter atom by atom in 3D will enable us to design materials that are stronger and lighter, more robust in extreme environments and provide economical solutions for energy, chemistry and informatics,” Ovchinnikova said.

Continue reading “Additive manufacturing techniques featuring atomic precision could one day create materials with Legos flexibility and Terminator toughness” »

Yale researchers have devised a method that brings marketable Li-O₂ batteries closer to reality, improving both the batteries’ performance and the ability to study them.

In recent years, lithium-oxygen batteries have intrigued researchers with their potential. They can store at least two to three times the energy as lithium-ion batteries can, which are the current standard for consumer electronics, so laptops could theoretically run longer on a single charge and electric cars would drive farther.

But they’re not quite there yet. For now, Li-O₂ batteries operate sluggishly and have short lives. Compounding matters, it’s hard to get a sense of how to fix that because figuring out the exact nature of their chemistry has proved tricky.

Continue reading “A New Design Strategy for Better Lithium Oxygen Batteries” »

Results from quantitative MRI and neuropsychological testing show unprecedented improvements in ten patients with early Alzheimer’s disease (AD) or its precursors following treatment with a programmatic and personalized therapy. Results from an approach dubbed metabolic enhancement for neurodegeneration are now available online in the journal Aging.

The study, which comes jointly from the Buck Institute for Research on Aging and the UCLA Easton Laboratories for Neurodegenerative Disease Research, is the first to objectively show that memory loss in patients can be reversed, and improvement sustained, using a complex, 36-point therapeutic personalized program that involves comprehensive changes in diet, brain stimulation, exercise, optimization of sleep, specific pharmaceuticals and vitamins, and multiple additional steps that affect brain chemistry.

“All of these patients had either well-defined mild cognitive impairment (MCI), subjective cognitive impairment (SCI) or had been diagnosed with AD before beginning the program,” said author Dale Bredesen, MD, a professor at the Buck Institute and professor at the Easton Laboratories for Neurodegenerative Disease Research at UCLA, who noted that patients who had had to discontinue work were able to return to work and those struggling at their jobs were able to improve their performance. “Follow up testing showed some of the patients going from abnormal to normal.”

Continue reading “Pre and post testing show reversal of memory loss from Alzheimer’s disease in 10 patients” »

A new study helps explain how brain structure and chemistry relate to “fluid intelligence” — the ability to adapt to new situations and solve problems one has never encountered before.

The study, reported in an open-access paper in the journal NeuroImage, observed two facets of fluid intelligence*:

Continue reading “Brain markers of numeric, verbal, and spatial reasoning abilities found” »

To start a fusion reaction, you have to create extreme conditions. A combination of stellar temperatures, incredible pressures and lightning-quick energy dumps have all been tried to create these conditions, with varying degrees of success.

In this post, we’ll look at a low-cost, low-energy method of achieving nuclear fusion. It’s not Cold Fusion, it’s Gun Fusion.

Understanding what’s difficult

Continue reading “Gun Fusion: Two barrels to the stars” »

Using numerical modelling, researchers from Russia, the US, and China have discovered previously unknown features of rutile TiO2, which is a promising photocatalyst. The calculations were performed at an MIPT laboratory on the supercomputer Rurik. A paper detailing the results has been published in the journal Physical Chemistry Chemical Physics.

It’s all on the surface

Special substances called catalysts are needed to accelerate or induce certain chemical reactions. Titanium dioxide (TiO2) is a good photocatalyst—when exposed to light, it effectively breaks down water molecules as well as hazardous organic contaminants. TiO2 is naturally found in the form of rutile and other minerals. One of the two most active surfaces of rutile R-TiO2 is a surface that is denoted as (011). The photocatalytic activity is linked to the way in which oxygen and titanium atoms are arranged on the surface. This is why it is important to understand which forms the surface of rutile can take.

I will be interested in seeing the results after more research done.

A team from the Indian Institute of Science (IISc), Bengaluru, has discovered an anticancer compound, which was isolated from a fungus that can be found in trees and plants. The team from IISc’s biochemistry lab, led by Prof C Jayabaskaran, for over a decade has been working on identification and extraction of natural compounds of pharmaceutical value found in well-known medicinal plants and their fungi. The latest chemical compound discovered is called “Cholestanol glucoside”.